Basic Informations

C.V

 Sameh Abdelmoneem Mohammed Ali
Page 1
Sameh Abdelmoneem Mohammed Ali
15 Elemam Abohanifa Street, ELhay- Elgharby , 62514 Beni-Suef (Egypt)
002-01148402671 sameh_abdelmonem@pharm.bsu.edu.eg
sameh.ali@pharm.bsu.edu.eg
same7_pharma18@yahoo.com
Academic Education
Work Experience
2014 –2015 M.Sc. degree in Pharmaceutical Sciences (Pharmacology & Toxicology)
''Pharmacological Study of the possible effects of temozolomide
nanoformulations in the treatment of lung cancer''.
2012 – 2013 Pre-Master courses with Excellent grade, Faculty of Pharmacy, Beni-Suef
University.
Advanced theoretical and practical courses in Pharmaceutical Statistics,
ComputerScience,ResearchMethodology&ScientificWriting,Pharmacometrics,
Toxicometrics, Immunopharmacology and Pathophysiology.
2006 – 2011 B.Sc. degree in Pharmaceutical Sciences, Excellent with honors (ranking the
5th on 2011 Batch, 280 students), Faculty of Pharmacy, Beni-Suef University.
Aug 2015 | Senior Teaching Assistant in Department of Pharmacology &
Toxicology, Faculty of Pharmacy, Beni-Suef University.
June 2012- 2015 | D e m o n s t r a tor in Department of Pharmacology & Toxicology, Faculty
of Pharmacy, Beni-Suef University.
Sameh Abdelmoneem Mohammed Ali
Page 2
Training courses & Workshops
Undergraduates
? Experimental Pharmacology: Demonstration of drug actions by experiments
performed on intact animals and isolated organ preparations.
? Forensic Toxicology.
? Case studies on Clinical Pharmacology and Therapeutics.
? First aid practical lessons.
Postgraduates
? Handling of laboratory animals.
? Biochemical analysis of blood samples.
Sep 2014 Participation in the 50th Congress of the European Societies of Toxicology
2014, Edinburgh International Conference Centre, Edinburgh, Scotland,
UK.
Sep 2013 Attendance of 53th Conference of ESPET (Egyptian Society of
Pharmacology and Experimental Therapeutics), British University of
Egypt (BUE), Shorok city, Egypt.
Dec 2014
Mar 2010
Attendance of 54th Conference of ESPET (Egyptian Society of
Pharmacology and Experimental Therapeutics), British University of
Egypt (BUE), Shorok city, Egypt.
Attendance of course entitled "Step on the way" which involve (C.V
writing, Communication skills & Patient councelling), Beni-Suef
University.
Sameh Abdelmoneem Mohammed Ali
Page 3
Apr 2015 Attendance of conference entitled "Biotechnology for the Emerging
Economies", Beni-Suef University Conference Centre, Beni-Suef, Egypt.
Feb - Mar 2014 Training courses for promoting knowledge and skills in: Effective
Presentation, Scientific Research and its Ethics, International Publishing,
Use of Technology in Teaching and Quality Standards in education.
Faculty and Leadership Development Center (FLDC), Beni-Suef
University.
May 2015 Participation as official representative of Beni-Suef University and Egypt in 7th
European Exhibition of Creativity and Innovation (EUROINVENT 2015),
Palas Mall, Iasi city, Romania.
Honors & Awards
May 2014 "Recent techniques in Molecular Biology" Workshop, Faculty of
Veterinary Medicine, Beni-Suef University.
Practicing on DNA & RNA Extraction, PCR & RT-PCR, Gel
Electrophoresis, Tissue Microarray and Western Blotting techniques.
Sep 2012
July 2009
Attendance of the first youth pharmacist's conference, Alexandria, Egypt.
Training in EIPICO (Egyptian International Pharmaceuticals Industries
CO), 10th of Ramadan city, Sharkia, Egypt.
Mar 2015 | A patent application has been filed by Egyptian Patent Office (EGPO),
Academy of scientific Research &Technology, Egypt. Patent title:
Temosome; A novel formula for treatment of lung cancer (333/2015).
May 2015 | Official Delegation Leader of egyptian team at 7th European Exhibition of
Creativity and Innovation (EUROINVENT 2015), Palas Mall, Iasi city,
Romania.
May 2015 | 2 Gold Medals from 7th European Exhibition of Creativity and Innovation
(EUROINVENT 2015), Palas Mall, Iasi city, Romania for the invention
entitled " Temosome; A novel formula for treatment of lung cancer".
Sameh Abdelmoneem Mohammed Ali
Page 4
Prize of Europe Direct Iasi for the best medical invention at 7th European
Exhibition of Creativity and Innovation (EUROINVENT 2015), Palas Mall,
Iasi city, Romania. The invention entitled " Temosome; A novel formula for
treatment of lung cancer".
Special Gold Medal from Nanomaterial Center, University of Iasi at 7th
European Exhibition of Creativity and Innovation (EUROINVENT 2015),
Palas Mall, Iasi city, Romania for the invention entitled " Temosome; A
novel formula for treatment of lung cancer".
Special Gold Medal from World Invention Intellectual Property Associations
(WIIPA), France; at 7th European Exhibition of Creativity and Innovation
(EUROINVENT 2015), Palas Mall, Iasi city, Romania for the invention
entitled " Temosome; A novel formula for treatment of lung cancer".
Special Award from Aydin New Ideas Association, Turkey; at 7th European
Exhibition of Creativity and Innovation (EUROINVENT 2015), Palas Mall,
Iasi city, Romania for the invention entitled " Temosome; A novel formula
for treatment of lung cancer".
Special Award from Beni-Suef University, Egypt; for its honourable
representation at 7th European Exhibition of Creativity and Innovation
(EUROINVENT 2015), Palas Mall, Iasi city, Romania.
Financial Award from Beni-Suef University, Egypt; for its honourable
representation at 7th European Exhibition of Creativity and Innovation
(EUROINVENT 2015), Palas Mall, Iasi city, Romania.
Publications
Sameh Mohammed A., Amira M Abo-youssef, Heba F. Salem, Mohamed A. Hamzawy.
Alternative animal model of urethane-induce lung cancer: A pilot study. Toxicology
Letters (2014).
http://www.sciencedirect.com/science/article/pii/S0378427414011849
Sameh Abdelmoneem Mohammed Ali
Page 5
Mohamed A. Hamzawy, Amira M Abo-youssef, Heba F. Salem, Sameh Mohammed A. An
additional risk of lung cancer from Recurrent Exposure to Ethyl Carbamate (EC) in
BALB/c Mice. Cancer Sciences and Therapy (2015).
http://www.omicsonline.org/open-access/an-additional-risk-of-lung-cancer-from-recurrentexposure-
to-ethylcarbamate-ec-in-balbc-mice-1948-5956-1000375.php?aid=64246
Sameh Mohammed A., Amira M Abo-youssef, Heba F. Salem, Mohamed A. Hamzawy. In
vivo assessment of intrapulmonary temozolomide nanoformulations for treatment of
lung cancer in BALB/c mice. Nanomedicine: Nanotechnology, Biology, and Medicine (2015)
accepted.
Participation with a poster in the 50th Congress of the European Societies of Toxicology
2014, Edinburgh International Conference Centre, Edinburgh, Scotland, UK.
Languages
Computer Skills
All Documens are available when requested.
Arabic | Mother Tongue.
English | IELTS (Overall Score 6.5) and TOEFL IDP (Score 560).
ICDL Certification | Good command of Microsoft office (Word, Excel, Access & Powerpoint).
iMindMap, Endnote X4 & X7, QIQQA and SPSS program softwares.
 

Master Title

Pharmacological Study of the Possible Effects of Temozolomide in the Treatment of Lung Cancer. Study of the Possible Effects of Temozolomide in the Treatment of Lung Cancer

Master Abstract

Lung cancer is one of the leading causes for death among other types of cancer and conventional chemotherapy pose extensive challenge including acquired cell resistance. The current study aimed to investigate the endotracheal inhalation (e.i) of temozolomide-loaded gold nanoparticles (TGNPs) or liposomes embedded temozolomide-loaded gold nanoparticles (LTGNPs) in treatment of urethane-induced lung cancer in BALB/C mice. Physicochemical characterization, zeta potential and electron microscope transmission were carried out for nanoparticle samples. In vivo study was performed for 19 weeks as follows (10 mice/group): group (1) untreated control; (2) treated with urethane (1.5mg/kg B.W, i.p) at day one and sixteen; group (3) treated with gold nanoparticles (GNPs100µ/kg B.w, e.i) once a week in the last three weeks; (4) treated with liposomes embedded gold nanoparticles (LGNPs 100µ/kg B.w, e.i) once a week in the last three weeks; groups (5) ,(6), (7) and (8) animals were pretreated with urethane at day one and day sixteen then treated with GNPs , LGNPs, TMZ-loaded gold nanoparticles (TGNPs,0.3mg/100µl/kg B.W, e.i) and liposomes embedded TMZ-loaded gold nanoparticles (LTGNPs,0.3mg/100µl/kg B.W, e.i), respectively once a week in the last three weeks. Lung and blood samples were collected for biochemical and histological examinations. The results showed that GNPs and LGNPs could be used as delivery system for chemotherapeutic agents. These findings revealed that endotracheal inhalation of TGNPs and LTGNPs are promising candidate for treatment of lung cancer due advanced localization of nanoparticles and drug targeting. Chemotherapeutic activity was pronounced in LTGNPs due to synergistic effect and increase time-release of chemotherapy

PHD Title

PHD Abstract